CCXI Earnings Surprises image   This CCXI earnings surprises page last updated 11/8/2022
CCXI Earnings Surprises Chart
PeriodExpectedActualSurprise
Q2 2022 -0.49 -0.44 +0.05 (-10%)
Q1 2022 -0.30 -0.55 -0.25 (+83%)
Q4 2021 -0.50 -0.58 -0.08 (+16%)
Q3 2021 -0.45 -0.32 +0.13 (-29%)
Q2 2021 -0.54 -0.56 -0.02 (+4%)
Q1 2021 -0.40 -0.43 -0.03 (+8%)
Q4 2020 -0.33 -0.43 -0.10 (+30%)
Q3 2020 -0.31 -0.35 -0.04 (+13%)
Q2 2020 -0.34 0.29 +0.63 (-185%)
Q1 2020 -0.30 -0.35 -0.05 (+17%)
Q3 2019 -0.28 -0.22 +0.06 (-21%)
Q2 2019 -0.22 -0.26 -0.04 (+18%)
Q1 2019 -0.24 -0.23 +0.01 (-4%)
Q4 2018 -0.27 -0.21 +0.06 (-22%)
Q3 2018 -0.24 -0.22 +0.02 (-8%)
Q2 2018 -0.15 -0.14 +0.01 (-7%)
Q1 2018 -0.25 -0.19 +0.06 (-24%)
Q4 2017 -0.20 0.80 +1.00 (-500%)
Q3 2017 -0.26 -0.13 +0.13 (-50%)
Q2 2017 -0.17 -0.19 -0.02 (+12%)
Q1 2017 -0.26 -0.12 +0.14 (-54%)
Q4 2016 -0.18 -0.16 +0.02 (-11%)
Q3 2016 -0.08 -0.15 -0.07 (+88%)
Q2 2016 0.07 -0.22 -0.29 (-414%)
Q3 2013 -0.26 -0.22 +0.04 (-15%)
Q2 2013 -0.28 -0.23 +0.05 (-18%)
Q1 2013 -0.27 -0.28 -0.01 (+4%)
CCXI Revenue Surprises Chart
PeriodExpectedActualSurprise
Q2 2022 13.07M 11.76M -1.31M (-10%)
Q1 2022 22.04M 5.46M -16.58M (-75%)
Q4 2021 11.62M 2.31M -9.30M (-80%)
Q3 2021 13.48M 17.74M +4.26M (+32%)
Q2 2021 4.85M 1.81M -3.04M (-63%)
Q1 2021 7.93M 10.35M +2.42M (+31%)
Q4 2020 7.99M 4.36M -3.63M (-45%)
Q3 2020 10.70M 5.08M -5.62M (-53%)
Q2 2020 8.25M 49.44M +41.19M (+499%)
Q1 2020 8.75M 6.01M -2.74M (-31%)
Q3 2019 7.70M 10.58M +2.88M (+37%)
Q2 2019 9.83M 7.17M -2.66M (-27%)
Q1 2019 10.97M 8.33M -2.64M (-24%)
Q4 2018 9.41M 9.33M -78000 (-1%)
Q3 2018 11.89M 8.97M -2.92M (-25%)
Q2 2018 14.06M 15.02M +962000 (+7%)
Q1 2018 6.30M 9.55M +3.25M (+52%)
Q4 2017 9.40M 56.30M +46.90M (+499%)
Q3 2017 9.03M 9.03M -1000 (0%)
Q2 2017 8.50M 8.94M +437000 (+5%)
Q1 2017 5.30M 8.23M +2.93M (+55%)
Q4 2016 3.30M 4.89M +1.59M (+48%)
Q3 2016 1.20M 4.25M +3.05M (+254%)
Q2 2016 19.20M 2.79M -16.41M (-85%)
Q3 2013 1.97M 1.52M -0.45M (-23%)
Q2 2013 1.48M 1.89M +406000 (+28%)
Q1 2013 2.04M 1.93M -0.11M (-5%)
Quotes delayed 20 minutes

Email EnvelopeFree CCXI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

DuPont de Nemours (DD): 11/8/2022 6:00 AM
New Fortress Energy (NFE): 11/8/2022 6:00 AM
Northwest Natural Holding (NWN): 11/8/2022 6:00 AM
Squarespace (SQSP): 11/8/2022 6:00 AM
MannKind (MNKD): 11/8/2022 6:00 AM
Armada Hoffler Properties (AHH): 11/8/2022 6:00 AM
First Advantage (FA): 11/8/2022 6:00 AM
Triumph Group (TGI): 11/8/2022 6:00 AM
Vertex Energy (VTNR): 11/8/2022 6:00 AM
InfuSystems Holdings (INFU): 11/8/2022 6:00 AM

More from the Next Earnings Dates Calendar

Earnings History:

Adtran (ADTN): 11/7/2022 8:05 PM
Mosaic (MOS): 11/7/2022 5:30 PM
Manitowoc Co (MTW): 11/7/2022 5:00 PM
Lordstown Motors (RIDE): 11/7/2022 5:00 PM
Vishay Precision Group (VPG): 11/7/2022 5:00 PM
Riot Blockchain (RIOT): 11/7/2022 5:00 PM
Mueller Water Products (MWA): 11/7/2022 5:00 PM
Ashland Global Holdings (ASH): 11/7/2022 5:00 PM
HCW Biologics (HCWB): 11/7/2022 After close
DocGo (DCGO): 11/7/2022 After close

More from the Earnings History archive
ChemoCentryx (CCXI) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CDAK Historical Earnings
CDMO Historical Earnings
CDNA Historical Earnings
CDRE Historical Earnings
CDTX Historical Earnings
CDXC Historical Earnings
CELC Historical Earnings
CEMI Historical Earnings
CERC Historical Earnings
CERE Historical Earnings
On this page we presented the CCXI earnings surprises information for ChemoCentryx, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on CCXI (or any other given stock) can benefit from researching all of the ChemoCentryx past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this ChemoCentryx earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about CCXI's next earnings report. In your continued research on ChemoCentryx we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for CCXI. Thanks for visiting, and the next time you need to research CCXI earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: BRCD Price Target, LOCL Historical Stock Prices, TVPT shares outstanding history.

 

CCXI Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.